산사 추출물을 유효성분으로 함유하는 퇴행성 뇌질환 치료 및 예방용 조성물
    11.
    发明授权
    산사 추출물을 유효성분으로 함유하는 퇴행성 뇌질환 치료 및 예방용 조성물 有权
    一种组合物,其包含治疗和预防神经退行性疾病的山楂提取物

    公开(公告)号:KR101194974B1

    公开(公告)日:2012-10-25

    申请号:KR1020090122024

    申请日:2009-12-09

    Abstract: 본 발명은 장미과(Rosaceae)에 속하는 산리홍(
    Crataegus pinnatifida Bunge)의 성숙한 과실인 산사자의 추출물을 유효성분으로 함유하는 건망증 개선 및 퇴행성 뇌질환 치료용 약학 조성물 또는 건강 기능 식품에 관한 것으로서, 상세하게는 본 발명의 산사자 추출물은 스코폴라민에 의해 유도된 기억력 감퇴 동물군에서 수동회피실험(Passive avoidance test), Morris 수중 미로 실험(Morris water-maze test) 및 Y 미로 실험(Y-maze)에서 학습증진 및 공간지각능력을 높은 수준으로 향상시키는 탁월한 효능을 나타내므로 건망증 개선 및 퇴행성 뇌질환 치료에 유용한 약학 조성물 또는 건강 기능 식품을 제공한다.
    산사자, 추출물, 건망증, 퇴행성 뇌질환

    신선초 추출물을 유효성분으로 함유하는 퇴행성 뇌질환 치료 및 예방용 조성물
    12.
    发明公开
    신선초 추출물을 유효성분으로 함유하는 퇴행성 뇌질환 치료 및 예방용 조성물 有权
    包括神经痛治疗和预防神经衰弱性疾病的成分的组合物

    公开(公告)号:KR1020110064922A

    公开(公告)日:2011-06-15

    申请号:KR1020090121704

    申请日:2009-12-09

    Abstract: PURPOSE: A composition Angelica utilis makino extract is provided to suppress acetylcholine esterase, to improve learning ability, and to treat neurodegenerative diseases. CONSTITUTION: A pharmaceutical composition for preventing and treating neurodegenerative diseases contains Angelica utilis makino extract as an active ingredient. The Angelica utilis makino extract is a crude extract, non-polar solvent soluble extract, or polar solvent soluble extract. The crude extract is isolates using water, methanol, ethanol, butanol, or mixture solvent thereof. A health food for preventing and treating neurodegenerative diseases contains Angelica utilis makino extract as an active ingredient. The health food is manufactured in the form of powder, granule, tablet, capsule, or beverage.

    Abstract translation: 目的:提供当归枸杞提取物以抑制乙酰胆碱酯酶,提高学习能力和治疗神经退行性疾病。 构成:用于预防和治疗神经退行性疾病的药物组合物含有当归生精提取物作为活性成分。 当归提取物是粗提物,非极性溶剂可溶提取物或极性溶剂可溶提取物。 粗提物是使用水,甲醇,乙醇,丁醇或其混合溶剂分离的。 用于预防和治疗神经退行性疾病的保健食品含有当归生精提取物作为活性成分。 保健食品以粉末,颗粒,片剂,胶囊或饮料的形式制造。

    디커신을 유효성분으로 함유하는 약물 중독 및 금단 증상의 예방 및 치료용 조성물
    13.
    发明公开
    디커신을 유효성분으로 함유하는 약물 중독 및 금단 증상의 예방 및 치료용 조성물 有权
    作为预防和治疗药物治疗和戒断综合征的活性成分的组合物

    公开(公告)号:KR1020110064536A

    公开(公告)日:2011-06-15

    申请号:KR1020090121197

    申请日:2009-12-08

    Abstract: PURPOSE: A composition containing decursin is provided to reduce drug reference and to be used in a pharmaceutical composition and health food. CONSTITUTION: A pharmaceutical composition for preventing and treating drug addition and withdrawal symptom contains decursin as an active ingredient, isolated from Angelica gigas nakai. The drug is philopon, cocaine, amphetamine, morphine, or alcohol. A health food for preventing and treating drug addiction and withdrawl symptom contains decursin as an active ingredient, isolated from Angelica gigas nakai. The health food is manufactured in the form of tablet, capsule, pill, or liquid.

    Abstract translation: 目的:提供含有前胡素的组合物以减少药物参考,并用于药物组合物和保健食品。 构成:用于预防和治疗药物添加和戒毒症状的药物组合物含有作为活性成分的前胡素,从当归分离得到。 药物是philopon,可卡因,苯丙胺,吗啡或酒精。 用于预防和治疗吸毒成瘾症状的保健食品含有作为活性成分的前胡素,与当归分离。 保健食品以片剂,胶囊,丸剂或液体的形式制造。

    세신 추출물을 유효성분으로 함유하는 우울증의 예방 및 치료용 조성물
    16.
    发明公开
    세신 추출물을 유효성분으로 함유하는 우울증의 예방 및 치료용 조성물 有权
    包含异黄酮类化合物的提取物的组合物。 防止和处理泄漏的人力资源

    公开(公告)号:KR1020140050299A

    公开(公告)日:2014-04-29

    申请号:KR1020120116535

    申请日:2012-10-19

    CPC classification number: A61K36/26 A23L33/105 A23V2002/00 A23V2200/322

    Abstract: The present invention relates to a composition comprising an extract of Asarum heterotropoides as an active ingredient for preventing or treating depression. More specifically, the Asarum heterotropoides extract of the present invention is confirmed to have antidepressant effect, via forced swimming test and tail suspension test of mice, which strongly suppresses depression compared to a conventional antidepressant; thereby can be used for a pharmaceutical composition and a functional health food for preventing or treating depression.

    Abstract translation: 本发明涉及包含Asarum heterotropeides的提取物作为预防或治疗抑郁症的活性成分的组合物。 更具体地说,与传统的抗抑郁药相比,本发明的Asarum heterotropeides提取物通过强迫游泳试验和尾巴悬浮试验证实具有抗抑郁作用,其强烈抑制抑郁症; 从而可以用于药物组合物和用于预防或治疗抑郁症的功能保健食品。

    프로폴리스 추출물 또는 이로부터 분리된 크리신 화합물을 유효성분을 함유하는 알콜 중독 및 금단증상의 예방 및 치료용 조성물
    17.
    发明公开
    프로폴리스 추출물 또는 이로부터 분리된 크리신 화합물을 유효성분을 함유하는 알콜 중독 및 금단증상의 예방 및 치료용 조성물 无效
    包含用于预防和治疗酒精滥用症状或戒断症状的丙泊酚或其他分离物的提取物的组合物

    公开(公告)号:KR1020140050298A

    公开(公告)日:2014-04-29

    申请号:KR1020120116534

    申请日:2012-10-19

    CPC classification number: A23L33/10 A61K31/353 A61K35/63

    Abstract: The present invention relates to a composition for preventing and treating alcohol intoxication and withdrawal symptoms, which contains an extract of propolis or chrysin isolated therefrom as an active ingredient. Specifically, the extract of propolis or chrysin isolated therefrom of the present invention dose dependently decreases a self intake amount of alcohol in a self-administration experiment, which is a behavioral experiment technique suitable for researching behavioral measurement related to drug-taking and drug-seeking. By ascertaining the fact that the above characteristic has no influence on a sucrose reinforcing effect when experimenting sucrose self-taking through a 20% sucrose solution intake to check whether or not the above characteristic influences a natural reinforcing effect, the composition can be used as a pharmaceutical composition and a health supplement for preventing and treating alcohol intoxication and withdrawal symptoms.

    Abstract translation: 本发明涉及一种用于预防和治疗酒精中毒和戒断症状的组合物,其含有作为活性成分从其中分离出的蜂胶或木质素提取物。 具体地说,本发明的蜂胶提取物或与其分离的chrysin剂量依赖性地降低自身实验中的自身摄取量,这是适用于研究与吸毒和寻求药物相关的行为测量的行为实验技术 。 通过确定当通过20%蔗糖溶液摄入实验蔗糖自体摄取时,上述特征对蔗糖增强效果没有影响,以检查上述特征是否影响天然增强效果,该组合物可以用作 药物组合物和预防和治疗酒精中毒和戒断症状的健康补充剂。

    산사 추출물을 유효성분으로 함유하는 퇴행성 뇌질환 치료 및 예방용 조성물
    20.
    发明公开
    산사 추출물을 유효성분으로 함유하는 퇴행성 뇌질환 치료 및 예방용 조성물 有权
    包含CRATAEGUS PINNATIFIDA治疗和预防神经变性疾病的提取物的组合物

    公开(公告)号:KR1020110065151A

    公开(公告)日:2011-06-15

    申请号:KR1020090122024

    申请日:2009-12-09

    CPC classification number: A61K36/734 A23L33/105 A23V2200/322 A61K2236/333

    Abstract: PURPOSE: A composition containing Crataegus pinnatifida Bunge extract is provided to improve learning ability and space perception and to treat neurodegenerative diseases. CONSTITUTION: A pharmaceutical compsotiion for preventing and treating neurodegenerative diseases contains Crataegus pinnatifida Bunge extract as an active ingredient. The Crataegus pinnatifida Bunge extract is isolated using water, low alcohol of C1-C4, or mixture solvent thereof. A health food for preventing and treating amnesia and neurodegenerative diseases contains Crataegus pinnatifida Bunge extract as an active ingredient. The health food is used in the form of powder, granule, tablet, capsule, or beverage.

    Abstract translation: 目的:提供含有山楂提取物的组合物,以提高学习能力和空间感知,并治疗神经退行性疾病。 构成:用于预防和治疗神经退行性疾病的药物动力学包含山楂提取物作为活性成分。 使用水,C1-C4的低级醇或其混合溶剂分离山楂提取物。 用于预防和治疗遗忘症和神经退行性疾病的保健食品含有山楂提取物作为活性成分。 保健食品以粉末,颗粒,片剂,胶囊或饮料的形式使用。

Patent Agency Ranking